SARS-CoV-2 challenge studies: ethics and risk minimisation

COVID-19 poses an exceptional threat to global public health and well-being. Recognition of the need to develop effective vaccines at unprecedented speed has led to calls to accelerate research pathways ethically, including by conducting challenge studies (also known as controlled human infection st...

Descripción completa

Detalles Bibliográficos
Autores principales: Bull, Susan, Jamrozik, Euzebiusz, Binik, Ariella, Parker, Michael J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Current Controversy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520819/
https://www.ncbi.nlm.nih.gov/pubmed/32978304
http://dx.doi.org/10.1136/medethics-2020-106504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520819/
https://www.ncbi.nlm.nih.gov/pubmed/32978304
http://dx.doi.org/10.1136/medethics-2020-106504

Ejemplares similares